Blade(BLDE) - 2023 Q2 - Quarterly Report

Passenger segment Medical segment bl f C Medical Adjusted EBITDA increased by $2.8 million or 138$2.1 million in same period of 2022 to $4.9 million in 2023. The increase is attributable to$5.2 million increase in Flight Profit due to higher revenue driven by the addition of new clients, growth within existing clients and organ transplant market growth, partially offset by a $2.4 million increase in fixed costs, primarily staff costs in order to support the hi ...